Pharmacokinetic evaluation in APP/PS-1 transgenic mice showed prolonged circulation time and enhanced brain accumulation of Tf-Ost-Lip, correlating with the amelioration of AD-associated pathological manifestations compared to unmodified osthole [110]. This evidence concerns the gene APP and Alzheimer disease.